Dr. Reddy's Laboratories Ltd. header image

Dr. Reddy's Laboratories Ltd.

500124

Equity

ISIN INE089A01031 / Valor 138953781

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-16)
INR 1,380.00+0.22%

Dr. Reddy's Laboratories Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dr. Reddy's Laboratories Ltd., headquartered in Hyderabad, India, is a multinational pharmaceutical company with core businesses in generics (branded and unbranded, including biosimilars), active pharmaceutical ingredients (APIs) and services (development, manufacturing and research support), innovative medicines and consumer health products; it also grows its portfolio through in‑licensing and partnerships. The company has commercialized a bevacizumab biosimilar in the UK, is collaborating with Gilead Sciences to manufacture and commercialize the long‑acting HIV treatment lenacapavir across multiple countries, and has brought an approved immunotherapy for recurrent or metastatic nasopharyngeal carcinoma into the Indian market, reflecting a strategic mix of generic manufacturing, specialty biologics and partnership‑led innovation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

10.8%1Y
24.5%3Y
43.2%5Y

Performance

23.9%1Y
21.8%3Y
21.7%5Y

Volatility

Market cap

12297 M

Market cap (USD)

Daily traded volume (Shares)

128,653

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Inc Supernus Pharmaceuticals Inc Valor: 18393960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-32.85%USD 28.15
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.31%CHF 0.92
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.73%USD 6.77
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%CHF 108.75
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%CHF 91.40
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.71%CHF 14.05
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.91%USD 74.77
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%USD 264.73
UCB SA
UCB SA UCB SA Valor: 986410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%EUR 295.10
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%EUR 24.30